A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409



Zeguo Zhao, Maud Condomines, Sjoukje J C van der Stegen, Fabiana Perna, Christopher C Kloss, Gertrude Gunset, Jason Plotkin, Michel Sadelain. Cancer Cell 2015
Times Cited: 369




List of shared articles



Times cited

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.
Christina Amatya, Melissa A Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi, Stephen M Hewitt, Steven A Feldman, James N Kochenderfer. Mol Ther 2021
10

Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment.
Norihiro Watanabe, Mary Kathryn McKenna, Amanda Rosewell Shaw, Masataka Suzuki. Mol Ther 2021
7

Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy.
Stella Bouziana, Dimitrios Bouzianas. Crit Rev Oncol Hematol 2021
2

CD137+ T-Cells: Protagonists of the Immunotherapy Revolution.
Alessio Ugolini, Marianna Nuti. Cancers (Basel) 2021
1


Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy.
Robert D Leone, Jonathan D Powell. Cancer Immunol Res 2021
1

Chimeric Antigen Receptor Design Today and Tomorrow.
Justin C Boucher, Marco L Davila. Cancer J 2021
0


CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities.
Maryam Akhoundi, Mahsa Mohammadi, Seyedeh Saeideh Sahraei, Mohsen Sheykhhasan, Nashmin Fayazi. Cell Oncol (Dordr) 2021
2

Trispecific CD19-CD20-CD22-targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models.
Dina Schneider, Ying Xiong, Darong Wu, Peirong Hu, Leah Alabanza, Brittany Steimle, Hasan Mahmud, Kim Anthony-Gonda, Winfried Krueger, Zhongyu Zhu,[...]. Sci Transl Med 2021
8

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma.
Deming Duan, Keke Wang, Cheng Wei, Dudu Feng, Yonghua Liu, Qingyan He, Xing Xu, Chunling Wang, Shuping Zhao, Leili Lv,[...]. Front Immunol 2021
0

Cellular networks controlling T cell persistence in adoptive cell therapy.
Jack D Chan, Junyun Lai, Clare Y Slaney, Axel Kallies, Paul A Beavis, Phillip K Darcy. Nat Rev Immunol 2021
1

Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
Zhiliang Bai, Stefan Lundh, Dongjoo Kim, Steven Woodhouse, David M Barrett, Regina M Myers, Stephan A Grupp, Marcela V Maus, Carl H June, Pablo G Camara,[...]. J Immunother Cancer 2021
1

Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models.
Yujing Xuan, Yuqiao Sheng, Daiqun Zhang, Kai Zhang, Zhen Zhang, Yu Ping, Shumin Wang, Xiaojuan Shi, Jingyao Lian, Kangdong Liu,[...]. Transl Oncol 2021
0

The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma.
Albert Oriol, Laura Abril, Anna Torrent, Gladys Ibarra, Josep-Maria Ribera. Ther Adv Hematol 2021
0

A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
3

The potential of CAR T cell therapy for prostate cancer.
Philipp Wolf, Jamal Alzubi, Christian Gratzke, Toni Cathomen. Nat Rev Urol 2021
0

CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges.
Mayur Narkhede, Amitkumar Mehta, Stephen M Ansell, Gaurav Goyal. Ann Transl Med 2021
0

Immunotherapies in Non-Hodgkin's Lymphoma.
Christine Bezombes, Patricia Pérez-Galán. Cancers (Basel) 2021
0

Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma.
Niels W C J van de Donk, Maria Themeli, Saad Z Usmani. Blood Cancer Discov 2021
1


PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
Yamin Jie, Guijun Liu, Lina Feng, Ying Li, Mingyan E, Liangliang Wu, Yinyin Li, Guanghua Rong, Yongwu Li, Huafeng Wei,[...]. Front Immunol 2021
0

Improving CAR T-Cell Persistence.
Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Marincola. Int J Mol Sci 2021
0

THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.
Chuang Sun, Peishun Shou, Hongwei Du, Koichi Hirabayashi, Yuhui Chen, Laura E Herring, Sarah Ahn, Yang Xu, Kyogo Suzuki, Guangming Li,[...]. Cancer Cell 2020
28

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability.
Sonia Guedan, Aviv Madar, Victoria Casado-Medrano, Carolyn Shaw, Anna Wing, Fang Liu, Regina M Young, Carl H June, Avery D Posey. J Clin Invest 2020
39

Immunotherapy of multiple myeloma.
Simone A Minnie, Geoffrey R Hill. J Clin Invest 2020
22